Genomics: Hepatitis C virus gets personal.
Iadonato
Shawn P
SP
Katze
Michael G
MG
D001741:Black or African American / Q000235:genetics; D044466:Asian People / Q000235:genetics; D002986:Clinical Trials as Topic; D005060:Europe / Q000208:ethnology; D055106:Genome-Wide Association Study; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000208:ethnology / Q000235:genetics* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D007372:Interferons; D007378:Interleukins / Q000235:genetics*; D010597:Pharmacogenetics; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011994:Recombinant Proteins; D019562:Viral Load; D000095022:Interferon Lambda
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007372:Interferons; D007378:Interleukins; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; C000624353:interferon-lambda, human; D000095022:Interferon Lambda; C417083:peginterferon alfa-2b